Day: January 11, 2022
LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the initation of a U.S. clinical trial evaluating the performance of its T2Biothreat® Panel designed to support a submission to the U.S. Food and Drug Administration (FDA).
The T2Biothreat® Panel, which runs on T2 Biosystems’ T2Dx® Instrument, is a direct-from-blood test panel that provides results in 3-5 hours and simultaneously detects six biothreat pathogens identified as threats by the U.S. Government, including B. anthracis, F. tularensis, Burkholderia spp., Y. pestis, and R. prowazekii.
The Company plans to file the FDA submission for the T2Biothreat® Panel in 2022 following completion of the clinical trial, which includes positive samples being prepared and analyzed...
CEA Industries Inc. Announces New Senior Vice President of Corporate Development
Written by Customer Service on . Posted in Public Companies.
Names Ryan Gift to CEA Industries Management Team
Louisville, Colorado, Jan. 11, 2022 (GLOBE NEWSWIRE) — CEA Industries Inc. (the “Company”) (OTCQB: SRNA), a leader in controlled environment agriculture (CEA) systems engineering and technologies, announced today the appointment of Ryan Gift as Senior Vice President of Corporate Development of the Company, effective immediately. Mr. Gift is a seasoned M&A executive with over 15 years of leadership experience.
“We are delighted to announce that Ryan will be assuming leadership of our corporate development initiatives as we continue to execute on our previously announced strategic growth plans,” said Tony McDonald, CEA Industries CEO. “I’m excited to have an executive of Ryan’s caliber to help CEA Industries achieve even greater levels of success.” Ryan adds, “I am very pleased...
Sun Pacific Holding Corp. announces its subsidiary Sun Pacific Power now providing Nano Solar Panels; “CIG’s industry market capacity to reach USD 8.5 billion by 2024”
Written by Customer Service on . Posted in Public Companies.
MANALAPAN, N.J., Jan. 11, 2022 (GLOBE NEWSWIRE) — Sun Pacific Holding Corp. (OTC: SNPW) is pleased to announce Sun Pacific Power “NANO SOLAR” panels offering worldwide sales and capacity for up to 50 MW per year. With this new product line Sun Pacific will have the opportunity to provide nano technology and building integrated solar panels that can deliver greater efficiency.
Nicholas Campanella, CEO of Sun Pacific Holding Corp. said, “We are excited to bring to the emerging renewable energy market this state-of-the-art technology to expand our solar footprint and offer Nano Solar CIGs on a worldwide level. Our product will be used for various applications and offering light weight panel technology with the option to provide various colored solar panels for building facades and reducing roof loads.”
Sun Pacific Power CIGS modules...
“Dog the Bounty Hunter” Signs with Virtual Interactive Technologies to Develop Multiple Video Games Around His Persona
Written by Customer Service on . Posted in Public Companies.
Denver, Colorado, Jan. 11, 2022 (GLOBE NEWSWIRE) — Virtual Interactive Technologies Corp., (OTC: VRVR) (“VRVR” or the “Company”), a multi-platform video gaming company, is pleased to announce that it has signed a multi-year, multi-game agreement with a production entity representing Duane “Dog” Chapman, aka “Dog the Bounty Hunter”.
Virtual Interactive Technologies will develop and market a line of video games in cooperation with the production entity and will use Mr. Chapman’s name, image, and likeness in connection with the advertisement, promotion, and sale of the video games. For more than a decade, Mr. Chapman has entertained his fans with multiple hit television series. In addition to capturing over 10,000 fugitives in his career, he has also captured millions of followers on social media. Virtual Interactive Technologies...
Trillion Energy Comments on Natural Gas Price Increases
Written by Customer Service on . Posted in Public Companies.
Natural Gas prices increase to historic highs of US$13.07/MCF
VANCOUVER, British Columbia, Jan. 11, 2022 (GLOBE NEWSWIRE) — Trillion Energy International Inc. (“Trillion” or the “Company”) (CSE: TCF) (OTC: TCFF) (Frankfurt: 3P2N) recently received a price increase for sale of natural gas to approximately USD $13.07/mcf amid seasonal supply shortages and strong regional demand. The price increase was effective January 2022.
In contrast this USD $13.07/mcf, the average natural gas sale price received during 2021 was approximately USD $8.84/mcf.
The Company believes a trifecta of circumstances have resulted in the sudden sharp price increase, which include increased demand due to a cold winter, alternate energy sources being shut down (such as several nuclear power plants in Germany), delays in increased supply of natural gas from...
Matterport Appoints Rob Hines as Managing Director to Drive Growth in the Americas
Written by Customer Service on . Posted in Public Companies.
Veteran sales executive from Oracle and salesforce.com to lead company’s sales to accelerate new business growth in the region
SUNNYVALE, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) — Matterport, Inc. (Nasdaq: MTTR), the leading spatial data company driving the digital transformation of the built world, today announced that Rob Hines has joined the company as Managing Director, Americas. Hines will oversee sales efforts across the region, including new business and revenue growth, people management and the execution of Matterport’s strategic vision.
“As we continue to innovate and expand Matterport’s products and services, it’s important that we have the right leaders in all of our high-growth markets to support our vision and capture the enormous addressable market,” said Jay Remley, Chief Revenue Officer of Matterport. “Rob’s extensive...
Aligos Therapeutics Expands Collaboration with Merck to Develop Oligonucleotide Therapies for NASH
Written by Customer Service on . Posted in Public Companies.
SOUTH SAN FRANCISCO, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that it has expanded its ongoing collaboration agreement with Merck to discover and develop oligonucleotide therapies for non-alcoholic steatohepatitis (NASH).
“We believe that one of our strengths as a company is our technical know-how in several areas of oligonucleotide research and development,” said Lawrence Blatt, Ph.D., MBA, Chairman and Chief Executive Officer of Aligos. “We are pleased to broaden our collaboration where we may be able to contribute to creating effective, targeted therapies for NASH together with Merck.”
Under the original agreement, Merck and Aligos...
BlackLine Announces Date for Fourth Quarter and Full Year 2021 Earnings Release and Conference Call
Written by Customer Service on . Posted in Public Companies.
LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) — BlackLine, Inc. (Nasdaq: BL) announced today that it will release financial results for the fourth quarter and full year ended December 31, 2021 after market close on Thursday, February 10, 2022 followed by a conference call hosted by management at 2:00 p.m. PT / 5:00 p.m. ET. A live webcast will be accessible on BlackLine’s investor relations website at https://investors.blackline.com/. The call can also be accessed domestically at (844) 229-7595 and internationally at (314) 888-4260, passcode 1426609.
A telephonic replay will be available through Thursday, February 17, 2022 at (855) 859-2056 or (404) 537-3406, passcode 1426609. A replay of the webcast will be available at https://investors.blackline.com/ for 12 months.
About BlackLine
Companies come to BlackLine (Nasdaq: BL) because...
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2021 Results
Written by Customer Service on . Posted in Public Companies.
LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced preliminary unaudited financial and operational results for the fourth quarter and full year 2021.
Recent Highlights (unaudited)Achieved full year 2021 total revenue of $27.7 million, including product revenue of $16.7 million, representing an increase of 53% and 43%, respectively compared to the prior year
Achieved fourth quarter total revenue of $6.6 million, including fourth quarter product revenue of $4.0 million
Executed contracts for 32 T2Dx® Instruments in 2021, including 17 T2Dx® Instrument contracts during the fourth quarter, consisting of 3 from the U.S. and 14 from outside the U.S.
Generated full year 2021 U.S. sepsis test panel revenue of $5.1 million, representing...
CN to Report Fourth-Quarter and Full-Year 2021 Financial and Operating Results on January 25, 2022
Written by Customer Service on . Posted in Public Companies.
MONTREAL, Jan. 11, 2022 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) will issue its fourth-quarter and full-year 2021 financial and operating results after the market close on January 25, 2022.
CN’s senior officers will review the results and the railway’s outlook in a conference call starting at 4:30 p.m. Eastern Time on January 25. JJ Ruest, CN President and Chief Executive Officer, will lead the call.
Parties wishing to participate via telephone may dial 1-866-324-3683 (Canada/U.S.), or 1-509-844-0959 (International), using 1523718 as the passcode. Participants are advised to dial in 10 minutes prior to the call.
CN will webcast the presentation live and furnish slides supporting the officers’ remarks via the Investors section of its website at www.cn.ca/en/investors. A webcast replay will be available after...